5’-O-(4,4’-Dimethoxytrityl)-3’-O-t-butyldimethylsilyl adenosine

CAT:
804-HY-W560806
Size:
Inquire

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
5’-O-(4,4’-Dimethoxytrityl)-3’-O-t-butyldimethylsilyl adenosine - image 1

5’-O-(4,4’-Dimethoxytrityl)-3’-O-t-butyldimethylsilyl adenosine

  • CAS Number:

    81794-12-9
  • UNSPSC Description:

    5’-O-(4,4’-Dimethoxytrityl)-3’-O-t-butyldimethylsilyl adenosine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1].
  • Target Antigen:

    Nucleoside Antimetabolite/Analog
  • Type:

    Oligonucleotides
  • Related Pathways:

    Cell Cycle/DNA Damage
  • Applications:

    Cancer-programmed cell death
  • Field of Research:

    Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/5-o-4-4-dimethoxytrityl-3-o-t-butyldimethylsilyl-adenosine.html
  • Solubility:

    10 mM in DMSO
  • Smiles:

    NC1=NC=NC2=C1N=CN2[C@H]3[C@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](COC(C4=CC=CC=C4)(C5=CC=C(OC)C=C5)C6=CC=C(OC)C=C6)O3
  • Molecular Weight:

    683.87
  • References & Citations:

    [1]Man S, et al. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today. 2021 Jun;26(6):1490-1500.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    No Development Reported